Intra-articular injection of non–cross-linked sodium hyaluronate for treatment of shoulder osteoarthritis
Record ID 32014001212
English
Authors' recommendations:
Osteoarthritis (OA) is a degenerative disease of the joints that leads to pain and disability. OA of the shoulder is the result of deterioration of the articular surface of the humeral head and glenoid, specifically, degeneration of cartilage and narrowing of the glenohumeral joint space. There are medical and surgical treatment options for shoulder OA. First-line therapy is conservative consisting of nonsteroidal anti-inflammatory drugs, physical therapy, corticosteroids, activity modification, and viscosupplementation. If symptoms are severe and disabling and unresponsive to medical therapy, the patient may require arthroscopy or partial or total shoulder joint replacement.
Details
Project Status:
Completed
Year Published:
2014
URL for published report:
The report may be purchased from: http://www.hayesinc.com/hayes/crd/?crd=16770
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Humans
- Hyaluronic Acid
- Osteoarthritis
- Injections, Intra-Articular
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
2014 Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.